Trump administration: Drugmakers that hiked prices may create 'tipping point'

President Donald Trump
The Trump administration said Monday it is closely watching reports of drug increases. (The White House)

The secretary of HHS had a direct message on Monday for the pharmaceutical companies that have hiked the prices of their products in recent months: The president sees you. 

Speaking at an event hosted by the 340B Coalition, he alluded to a tweet earlier in the day from the commander-in-chief specifically calling out drug giant Pfizer and other drug companies for hiking their prices in recent months.

Pfizer hiked prices on about 40 drugs as of July 1, FiercePharma reported

Free Daily Newsletter

Like this story? Subscribe to FierceHealthcare!

The healthcare sector remains in flux as policy, regulation, technology and trends shape the market. FierceHealthcare subscribers rely on our suite of newsletters as their must-read source for the latest news, analysis and data impacting their world. Sign up today to get healthcare news and updates delivered to your inbox and read on the go.

Suggested Articles

To build scale and drive greater savings, providers in some regions are banding together in statewide Medicare accountable care organizations. 

CMS issued updated Medicaid guidance on regulations for state-run home and community-based services.

Regulators warn that suggestions to address surprise bills, such as rate setting and payment caps, come with significant downsides for states.